PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in the development of molecular imaging products, announced today that two presentations were made on the Company’s 18F-AV-45 PET radiopharmaceutical for the molecular imaging of amyloid aggregates in the brain at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease meeting, being held in Vienna, Austria, from July 11-16, 2009.
